Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Serre-Yu Wong"'
Autor:
Simone Dallari, Vicky Martinez Pazos, Juan Munoz Eusse, Judith Wellens, Craig Thompson, Jean-Frederic Colombel, Jack Satsangi, Ken Cadwell, Serre-Yu Wong, ICARUS-IBD Working Group
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract While differential antibody responses SARS-CoV-2 in patients with inflammatory bowel disease (IBD) receiving infliximab and vedolizumab are well-characterized, the immune pathways underlying these differences remain unknown. Prior to COVID-1
Externí odkaz:
https://doaj.org/article/d097121319674b2b89b25aece89b4326
Autor:
Serre-Yu Wong, Ken Cadwell
Publikováno v:
PLoS Pathogens, Vol 14, Iss 9, p e1007215 (2018)
Externí odkaz:
https://doaj.org/article/116a332190744cc2a2ce711a24554059
Publikováno v:
Journal of Crohn's and Colitis. 15:1376-1386
Since the beginning of the pandemic, patients with inflammatory bowel diseases [IBD] have been considered at high risk for infection and complications of COVID-19. IBD patients and patients taking immunosuppressive therapy were excluded from clinical
Autor:
Jane C Figueiredo, Fred R Hirsch, Lawrence H Kushi, Wendy N Nembhard, James M Crawford, Nicholas Mantis, Laurel Finster, Noah M Merin, Akil Merchant, Karen L Reckamp, Gil Y Melmed, Jonathan Braun, Dermot McGovern, Samir Parekh, Douglas A Corley, Namvar Zohoori, Benjamin C Amick, Ruofei Du, Peter K Gregersen, Betty Diamond, Emanuela Taioli, Carlos Sariol, Ana Espino, Daniela Weiskopf, Alba Gifoni, James Brien, William Hanege, Marc Lipsitch, David A Zidar, Ann Scheck McAlearney, Ania Wajnberg, Joshua LaBaer, E Yvonne Lewis, Raquel A Binder, Ann M Moormann, Catherine Forconi, Sarah Forrester, Jennifer Batista, John Schieffelin, Dongjoo Kim, Giulia Biancon, Jennifer VanOudenhove, Stephanie Halene, Rong Fan, Dan H Barouch, Galit Alter, Swetha Pinninti, Suresh B Boppana, Sunil K Pati, Misty Latting, Andrew H Karaba, John Roback, Rafick Sekaly, Andrew Neish, Ahnalee M Brincks, Douglas A Granger, Amy B Karger, Bharat Thyagarajan, Stefani N Thomas, Sabra L Klein, Andrea L Cox, Todd Lucas, Debra Furr-Holden, Kent Key, Nicole Jones, Jens Wrammerr, Mehul Suthar, Serre Yu Wong, Natalie M Bowman, Viviana Simon, Lynne D Richardson, Russell McBride, Florian Krammer, Meenakshi Rana, Joshua Kennedy, Karl Boehme, Craig Forrest, Steve W Granger, Christopher D Heaney, Maria Knight Lapinski, Shannon Wallet, Ralph S Baric, Luca Schifanella, Marcos Lopez, Soledad Fernández, Eben Kenah, Ashish R Panchal, William J Britt, Iñaki Sanz, Madhav Dhodapkar, Rafi Ahmed, Luther A Bartelt, Alena J Markmann, Jessica T Lin, Robert S Hagan, Matthew C Wolfgang, Jacek Skarbinski
Publikováno v:
Open forum infectious diseases, vol 9, iss 6
Background Global efforts are needed to elucidate the epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the underlying cause of coronavirus disease 2019 (COVID-19), including seroprevalence, risk factors, and long-term seq
Publikováno v:
Gastroenterology. 162:2125-2126
Autor:
Wellens, Judith, Edmans, Matthew, Obolski, Uri, McGregor, Colleen G. C., Simmonds, Peter, Turner, Marc, Jarvis, Lisa, Skelly, Donal, Dunachie, Susanna, Barnes, Eleanor, Eyre, David W., Colombel, Jean-Frederic, Serre-Yu Wong, Klenerman, Paul, Lindsay, James O., Satsangi, Jack, Thompson, Craig P.
Publikováno v:
Gut; Sep2022, Vol. 71 Issue 9, p1919-1922, 4p
ObjectiveThe impact of medications on COVID-19 vaccine efficacy in IBD patients is unknown, as patients with immunosuppressed states and/or treated with immunosuppressants were excluded from vaccine trials. To address this, we evaluated serological r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::738704c391eb5b33181d40184fcb852c
https://doi.org/10.1101/2021.03.17.21253848
https://doi.org/10.1101/2021.03.17.21253848
Autor:
Serre-Yu Wong, Emma K. Accorsi, Rebekah E. Dixon, J.-F. Colombel, Susan Zolla-Pazner, Drew Helmus, Cowger Tl, Damodara Rao Mendu, Navalurkar R, Wiseman D, Adolfo Firpo-Betancourt, Stefan M. Gold, Ken Cadwell
Patients with immune-mediated inflammatory diseases (IMIDs) and acquired and genetic immunodeficiencies receiving therapeutic infusions are considered high risk for SARS-CoV-2 infection. However, the seroprevalance in this group and the safety of rou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af446bab3fd1e0b6ef966b8ddfcc8e14
https://doi.org/10.1101/2021.03.15.21253615
https://doi.org/10.1101/2021.03.15.21253615
Publikováno v:
The Lancet Gastroenterology & Hepatology. 6:781-782
Autor:
Erica Park, Rebekah E. Dixon, Serre-Yu Wong, David A. Greenwald, Nikhil A. Kumta, Zoe Gottlieb, Loren Rabinowitz, Michelle K. Kim, Pascale M. White, Aimee L. Lucas, Yakira N. David, Lauren Tal Grinspan, Manasi Agrawal, Andrew Srisuwananukorn
Publikováno v:
American Journal of Gastroenterology. 116:S1356-S1357
Introduction: Prior data indicate that within procedural specialties, women may be less likely to be first and senior authors of manuscripts during the COVID-19 pandemic, especially for studies pertaining to the pandemic. Women are more likely faced